Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19 is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5T32AI007511-08
Training in Mechanisms of Parasitism
National Institutes of Health
Grant: 5R01AI134733-02
Modeling Filovirus Infection of and Trafficking through Skin
National Institutes of Health
Grant: 3P50CA070907-02S1
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCER
National Institutes of Health
Grant: 3U54CA260560-02S2
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
National Institutes of Health
Grant: 5T32GM007337-26
MEDICAL SCIENTIST TRAINING PROGRAM
NCI NIH HHS
Grant: U54 CA260560
NIAID NIH HHS
Grant: T32 AI007511
NCI NIH HHS
Grant: P50 CA070907
NIGMS NIH HHS
Grant: T32 GM007337
NIAID NIH HHS
Grant: R01 AI134733
Fields of Study
Keywords